KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Return on Invested Capital (2020 - 2025)

Historic Return on Invested Capital for TherapeuticsMD (TXMD) over the last 3 years, with Q3 2025 value amounting to 2.16%.

  • TherapeuticsMD's Return on Invested Capital changed N/A to 2.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.16%, marking a year-over-year change of. This contributed to the annual value of 0.17% for FY2024, which is 1000.0% up from last year.
  • Latest data reveals that TherapeuticsMD reported Return on Invested Capital of 2.16% as of Q3 2025.
  • In the past 5 years, TherapeuticsMD's Return on Invested Capital registered a high of 0.11% during Q2 2025, and its lowest value of 2.16% during Q3 2025.